Klingman & Associates’s Chemours CC Stock Holding History

Klingman & Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20	Closed	–	–	136
2016 Q3	$0	Hold	20	–	–	﹤0.01%	369
2016 Q2	$0	Hold	20	–	–	﹤0.01%	378
2016 Q1	$0	Hold	20	–	–	﹤0.01%	385
2015 Q4	$0	Hold	20	–	–	﹤0.01%	400
2015 Q3	$0	Buy	+20	New	+$209	﹤0.01%	423

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Klingman & Associates's CC Position: Q4 2016 in Review

Klingman & Associates sold out of Chemours (CC) in Q4 2016, closing a stake of 20 shares.

Klingman & Associates first reported a position in CC in Q3 2015 and held it in 5 quarters. The position peaked at $0 in Q3 2016. 416 funds tracked by Wall St. Rank hold CC as of Q4 2016.

Klingman & Associates reported no remaining Chemours position as of Q4 2016 after selling out during the quarter.
Klingman & Associates sold 20 Chemours shares in Q4 2016.
Klingman & Associates first reported a position in Chemours in Q3 2015 and held it in 5 quarters.
Klingman & Associates's Chemours position peaked at $0 in Q3 2016.
416 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.